Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Miyoung Yoon, Jerry L. Campbell, Melvin E. Andersen & Harvey J. Clewell. (2012) Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. Critical Reviews in Toxicology 42:8, pages 633-652.
Read now
Read now
S. Mitchell, R. Ayesh, T. Barrett, R. Smith. (1999) Trimethylamine and Foetor Hepaticus. Scandinavian Journal of Gastroenterology 34:5, pages 524-528.
Read now
Read now
P. V. Luoma, E. A. Sotaniemi & A. J. Arranto. (1983) Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics. Scandinavian Journal of Clinical and Laboratory Investigation 43:8, pages 671-675.
Read now
Read now
G. R. Wilkinson. (1979) The Application of Clearance Concepts to Propranolol Disposition in Man. Drug Metabolism Reviews 10:1, pages 107-123.
Read now
Read now
Articles from other publishers (75)
Matthias Hoch, Masahiko Sato, Julia Zack, Michelle Quinlan, Tirtha Sengupta, Alex Allepuz, Paola Aimone & Florence Hourcade‐Potelleret. (2021) Pharmacokinetics of Asciminib in Individuals With Hepatic or Renal Impairment. The Journal of Clinical Pharmacology 61:11, pages 1454-1465.
Crossref
Crossref
Miyoung Yoon, Gina Song, Harvey Clewell & Bas Blaauboer. 2019. Big Data in Predictive Toxicology. Big Data in Predictive Toxicology
331
358
.
Miyoung Yoon, Harvey J. ClewellIIIIII & Melvin E. Andersen. (2013) Deriving an explicit hepatic clearance equation accounting for plasma protein binding and hepatocellular uptake. Toxicology in Vitro 27:1, pages 11-15.
Crossref
Crossref
Richard Callaghan, Paul V Desmond & Maurice L Masheord. (1993) The effect of a nutritional model of chronic liver injury on the hepatic glucuronidation of morphine in rats. Journal of Pharmacy and Pharmacology 45:11, pages 998-999.
Crossref
Crossref
Fabrizio D'Esposito, Noelia Nebot, Robert J. Edwards & Michael Murray. (2010) Impaired irinotecan biotransformation in hepatic microsomal fractions from patients with chronic liver disease. British Journal of Clinical Pharmacology 70:3, pages 400-408.
Crossref
Crossref
Phillip S. Mushlin & Simon Gelman. 2010. Miller's Anesthesia. Miller's Anesthesia
411
440
.
John Timbrell. 2008. Principles of Biochemical Toxicology, Fourth Edition. Principles of Biochemical Toxicology, Fourth Edition
129
191
.
Theodosios Saranteas, Constantinos Mourouzis, Sophia Anagnostopoulou, Kostas Danis, Annete Tachmintzis & George Rallis. (2006) 14C-Lidocaine Disposition in Serum and Tissues of Normal and Liver Diseased Rats. Journal of Oral and Maxillofacial Surgery 64:6, pages 892-895.
Crossref
Crossref
A. Kotsiou, M. Tsamouri, S. Anagnostopoulou, M. Tzivras, E. Vairactaris & C. Tesseromatis. (2006) H3 Propranolol serum levels following lidocaine administration in rats with CCL4 — induced liver damage. European Journal of Drug Metabolism and Pharmacokinetics 31:2, pages 97-101.
Crossref
Crossref
Diane Wilson, Glenn R. Pettifer & Giselle Hosgood. (2006) Effect of transdermally administered fentanyl on minimum alveolar concentration of isoflurane in normothermic and hypothermic dogs. Journal of the American Veterinary Medical Association 228:7, pages 1042-1046.
Crossref
Crossref
Glenn R Pettifer & Giselle Hosgood. (2004) The effect of inhalant anesthetic and body temperature on peri-anesthetic serum concentrations of transdermally administered fentanyl in dogs. Veterinary Anaesthesia and Analgesia 31:2, pages 109-120.
Crossref
Crossref
E. Tanaka. (1998) Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease. Journal of Clinical Pharmacy and Therapeutics 23:3, pages 161-170.
Crossref
Crossref
P. C. MILLS, J. C. NG & D. E. AUER. (2008) The effect of inflammation on the disposition of phenylbutazone in Thoroughbred horses. Journal of Veterinary Pharmacology and Therapeutics 19:6, pages 475-481.
Crossref
Crossref
Jesper Sonne. (1996) Drug Metabolism in Liver Disease: Implications for Therapeutic Drug Monitoring. Therapeutic Drug Monitoring 18:4, pages 397-401.
Crossref
Crossref
G. Gordon Gibson & Paul SkettG. Gordon Gibson & Paul Skett. 1994. Introduction to Drug Metabolism. Introduction to Drug Metabolism
133
156
.
M. PERSICO, M. ROMANO, N. VILLANO, F. MONTELLA & S. GENTILE. (2008) The association between rifamycin‐SV (R‐SV) related hyperbilirubinaemia and antipyrine clearance as a new test of liver function in cirrhosis. European Journal of Clinical Investigation 24:3, pages 201-204.
Crossref
Crossref
Louise Gariépy, Daphna Fenyves, Ibrahim Kassissia & Jean-Pierre Villeneuve. (1993) Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple-indicator dilution technique. Hepatology 18:4, pages 823-831.
Crossref
Crossref
Simon Gelman & Luc Frenette. (1992) Effects of anaesthetics on liver blood flow. Baillière's Clinical Anaesthesiology 6:4, pages 729-750.
Crossref
Crossref
G.E. Burrows, J. Tasler, J.C. Boray & J. Egerton. (1992) Antipyrine, erythromycin and oxytetracycline disposition in experimental fasciolosis. Research in Veterinary Science 53:2, pages 191-197.
Crossref
Crossref
Russell E. Cowan, Barry T. Jackson, Stephen L. Grainger & Richard P. H. Thompson. (1991) Effects of anesthetic agents and abdominal surgery on liver blood flow. Hepatology 14:6, pages 1161-1166.
Crossref
Crossref
Georg Wensing, Heiner Mönig, Edgar E. Ohnhaus & Harald P. Hoensch. (1991) Pharmacokinetics of encainide in patients with cirrhosis. Cardiovascular Drugs and Therapy 5:4, pages 733-739.
Crossref
Crossref
F. Albani, M. R. Tamè, R. De Palma & M. Bernardi. (1991) Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis. European Journal of Clinical Pharmacology 40:4, pages 423-425.
Crossref
Crossref
Beat Meyer, Hesheng Luo, Mario Bargetzi, Eberhard L. Renner & Georg A. Stalder. (1991) Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: Support for the intact-hepatocyte theory. Hepatology 13:3, pages 475-481.
Crossref
Crossref
C. Drouet-Coassolo, A. Iliadis, P. Coassolo, M. Antoni & JP Cano. (1990) Pharmacokinetics of flunitrazepam following single dose oral administration in liver disease patients compared with healthy volunteers. Fundamental & Clinical Pharmacology 4:6, pages 643-651.
Crossref
Crossref
Steven Schenker & Anastacio M. Hoyumpa. 1991. Cirrhosis, Hepatic Encephalopathy, and Ammonium Toxicity. Cirrhosis, Hepatic Encephalopathy, and Ammonium Toxicity
209
226
.
Colin W. Howden, Gordon G. Birnie & Martin J. Brodie. (1989) Drug metabolism in liver disease. Pharmacology & Therapeutics 40:3, pages 439-474.
Crossref
Crossref
S. Gelman. 1989. Clinical Aspects of O2 Transport and Tissue Oxygenation. Clinical Aspects of O2 Transport and Tissue Oxygenation
384
396
.
Varocha Mahachai. 1989. Modern Concepts in Gastroenterology Volume 2. Modern Concepts in Gastroenterology Volume 2
129
157
.
Svein Øie & Yea Huei K. Yang. (1988) Effect of Altered Albumin Concentrations on Elimination of Unbound Prazosin In Vivo in the Rat and in the Isolated Perfused Rat Liver. Journal of Pharmaceutical Sciences 77:11, pages 948-951.
Crossref
Crossref
J. P. Villeneuve, M. J. Thibeault, M. Ampelas, H. Fortunet-Fouin, L. LaMarre, J. C�t�, G. Pomier-Layrargues & P. -M. Huet. (1987) Drug disposition in patients with HBsAg-positive chronic liver disease. Digestive Diseases and Sciences 32:7, pages 710-714.
Crossref
Crossref
P.L. Toutain, A. Autefage, M. Oukessou & M. Alvinerie. (1987) Pharmacokinetics of Methylprednisolone Succinate, Methylprednisolone, and Lidocaine in the Normal Dog and During Hemorrhagic Shock. Journal of Pharmaceutical Sciences 76:7, pages 528-534.
Crossref
Crossref
G. E. BURROWS, P. B. BARTO & B. R. WEEKS. (2008) Chloramphenicol, lincomycin and oxytetracycline disposition in calves with experimental pneumonic pasteurellosis. Journal of Veterinary Pharmacology and Therapeutics 9:2, pages 213-222.
Crossref
Crossref
I. El-Raghy, D.J. Back, F. Osman, M.L'E. Orme & M. Fathalla. (1986) Contraceptive steroid concentrations in women with early active schistosomiasis: Lack of effect of antischistosomal drugs. Contraception 33:4, pages 373-377.
Crossref
Crossref
B. Terhaag & U. Hermann. (1986) Biliary elimination of indomethacin in man. European Journal of Clinical Pharmacology 29:6, pages 691-695.
Crossref
Crossref
G. Gordon Gibson & Paul SkettG. Gordon Gibson & Paul Skett. 1986. Introduction to Drug Metabolism. Introduction to Drug Metabolism
147
174
.
Shepard Siegel. 1986. Research Advances in Alcohol and Drug Problems. Research Advances in Alcohol and Drug Problems
279
314
.
I. el‐Raghy, DJ Back, F. Osman, MA Nafeh & ML Orme. (2012) The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis.. British Journal of Clinical Pharmacology 20:4, pages 313-316.
Crossref
Crossref
R. Zaman, D. B. Jack, M. R. Wilkins & M. J. Kendall. (2006) Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: A single dose study. Biopharmaceutics & Drug Disposition 6:2, pages 131-137.
Crossref
Crossref
Hannu U. Saarni, Arno J. Arranto, Arja Rautio & Eero A. Sotaniemi. (1985) Treatment of liver cirrhosis with microsomal enzyme-inducing compound in the rat. Journal of Hepatology 1:5, pages 501-511.
Crossref
Crossref
M. Couvaris, P. Galanopoulou, Ch. Karageorgiou, H. Abdel Jalil & D. Varonos. (1985) Bioavailability of hetacillin in rats after liver enzyme induction by various inducers with or without protein binding properties. European Journal of Drug Metabolism and Pharmacokinetics 10:1, pages 27-32.
Crossref
Crossref
MW Teunissen, P Spoelstra, CW Koch, B Weeda, W van Duyn, AR Janssens & DD Breimer. (2012) Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.. British Journal of Clinical Pharmacology 18:5, pages 707-715.
Crossref
Crossref
F. Pisani, E. Perucca, G. Primerano, A. A. D'Agostino, R. M. Petrelli, A. Fazio, G. Oteri & R. Di Perri. (1984) Single-dose kinetics of primidone in acute viral hepatitis. European Journal of Clinical Pharmacology 27:4, pages 465-469.
Crossref
Crossref
Jorge J. Asconapé & J. Kiffin Penry. (1982) Use of Antiepileptic Drugs in the Presence of Liver and Kidney Diseases: A Review. Epilepsia 23:s1, pages S65-S79.
Crossref
Crossref
K. L. L. Fong, D. H. W. Ho, R. S. Benjamin, N. S. Brown, A. Bedikian, B. S. Yap, C. L. Wiseman, W. Kramer & G. P. Bodey. (1982) Clinical pharmacology of bruceantin by radioimmunoassay. Cancer Chemotherapy and Pharmacology 9:3, pages 169-172.
Crossref
Crossref
Karl E. Anderson, Allan H. Conney & Attallah Kappas. (2009) Nutritional Influences on Chemical Biotransformations in Humans. Nutrition Reviews 40:6, pages 161-171.
Crossref
Crossref
K.‐O. HAUSTEIN, G. HÜLLER & HELGA SENSING. (2008) The determination of aminopyrin elimination for control of the metabolic capacity of the liver in man. European Journal of Clinical Investigation 12:2, pages 157-164.
Crossref
Crossref
M. J. Brodie, A. R. Boobis, C. J. Bulpitt & D. S. Davies. (1981) Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. European Journal of Clinical Pharmacology 20:1, pages 39-46.
Crossref
Crossref
Mary Jeanne Kreek, F. Aladar Bencsath & Frank H. Field. (1980) Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: Quantitation by direct probe chemical ionization mass spectrometry. Biological Mass Spectrometry 7:9, pages 385-395.
Crossref
Crossref
K. Guest, A. J. McLean & C. V. Wellington. (2019) DRUG ASSAY SERVICES AND THERAPEUTIC DRUG USE IN A GENERAL HOSPITAL. Medical Journal of Australia 1:4, pages 167-170.
Crossref
Crossref
Mark D. Seefeld, Ralph M. Albrecht, Kennedy W. Gilchrist & Richard E. Peterson. (1980) Blood clearance tests for detecting 2,3,7,8-tetrachlorodibenzo-p-dioxin hepatotoxicity in rats and rabbits. Archives of Environmental Contamination and Toxicology 9:3, pages 317-327.
Crossref
Crossref
P. J. Pentik�inen, P. J. Neuvonen & K. -G. Jostell. (1980) Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver. European Journal of Clinical Pharmacology 17:4, pages 275-284.
Crossref
Crossref
E. Perucca & A. Richens. 1980. Drug-Induced Pathology. Drug-Induced Pathology
17
68
.
J. Noordhoek. (1979) Metabolisme van geneesmiddelen — algemene aspecten en enkele nieuwe ontwikkelingen. Pharmaceutisch weekblad 1:1, pages 33-42.
Crossref
Crossref
Mark D. Seefeld, Ralph M. Albrecht & Richard E. Peterson. (1979) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on indocyanine green blood clearance in rhesus monkeys. Toxicology 14:3, pages 263-272.
Crossref
Crossref
Ole Ladefoged. (1979) The Effect of Carbon Tetrachloride (CCl4) Induced Liver Damage on the Volume of Distribution, the Elimination Half-Life and body Clearance of Antipyrine and Warfarin in RabbitsVirkningen af tetraklorkulstof (CCl4) induceret leverbeskadigelse på fordelingsvolumen, halveringstid og body clearance af antipyrin og warfarin hos kaniner. Acta Veterinaria Scandinavica 20:3, pages 429-437.
Crossref
Crossref
C. T. Ueda & B. S. Dzindzio. (1979) Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration. European Journal of Clinical Pharmacology 16:2, pages 101-105.
Crossref
Crossref
A. Schaich Fries & O. Ladefoged. (1979) The Influence of Bacillus Piliformis (Tyzzer) Infections on the Reliability of Pharmacokinetic Experiments in Mice. Laboratory Animals 13:3, pages 257-262.
Crossref
Crossref
M Homeida, C J Roberts, M Halliwell, A E Read & R A Branch. (1979) Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease.. Gut 20:7, pages 596-601.
Crossref
Crossref
D.G. Shand. (1979) Hepatic Circulation and Drug Disposition in Cirrhosis. Gastroenterology 77:1, pages 184-186.
Crossref
Crossref
E. Andrew Neal, Peter J. Meffin, Peter B. Gregory & Terrence F. Blaschke. (1979) Enhanced Bioavailability and Decreased Clearance of Analgesics in Patients with Cirrhosis. Gastroenterology 77:1, pages 96-102.
Crossref
Crossref
A.J.J. Wood, J.P. Villeneuve, R.A. Branch, L.W. Rogers & D.G. Shand. (1979) Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat. Gastroenterology 76:6, pages 1358-1362.
Crossref
Crossref
R.A. Willson, F.E. Hart & J.T. Hew. (1979) Comparison of In Vivo and In Vitro Drug Metabolism in Experimental Hepatic Injury in the Rat. Gastroenterology 76:4, pages 697-703.
Crossref
Crossref
RODERICK K. ROBERTS, ROBERT A. BRANCH, PAUL V. DESMOND & STEVEN SCHENKER. (1979) The Influence of Liver Diseases on Drug Disposition. Clinics in Gastroenterology 8:1, pages 105-121.
Crossref
Crossref
G. R. WILKINSON. (2008) The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man. Acta Psychiatrica Scandinavica 58:S274, pages 56-74.
Crossref
Crossref
Ruben A. Zito & Philip R. Reid. (1978) Lidocaine Kinetics Predicted by Indocyanine Green Clearance. New England Journal of Medicine 298:21, pages 1160-1163.
Crossref
Crossref
J. Noordhoek, J. Dees, E. M. Savenije-Chapel & J. H. P. Wilson. (1978) Output of14CO2 in breath after oral administration of (14C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: Its relationship to aminopyrine pharmacokinetics. European Journal of Clinical Pharmacology 13:3, pages 223-229.
Crossref
Crossref
U. Klotz, T. Rapp & W. A. M�ller. (1978) Disposition of valproic acid in patients with liver disease. European Journal of Clinical Pharmacology 13:1, pages 55-60.
Crossref
Crossref
C. A. Naranjo, U. Busto & R. Mardones. (1978) Adverse drug reactions in liver cirrhosis. European Journal of Clinical Pharmacology 13:6, pages 429-434.
Crossref
Crossref
R.A. Willson & F.E. Hart. (1977) Effect of Experimental Hepatic Injury on in vitro Drug-Metabolizing Enzyme Activities in the Rat. Gastroenterology 73:4, pages 691-696.
Crossref
Crossref
KENNETH BACHMANN, RONALD SHAPIRO & JAMES MACKIEWICZ. (1977) Warfarin Elimination and Responsiveness in Patients with Renal Dysfunction. The Journal of Clinical Pharmacology 17:5-6, pages 292-299.
Crossref
Crossref
Terrence F. Blaschke. (2012) Protein Binding and Kinetics of Drugs in Liver Diseases. Clinical Pharmacokinetics 2:1, pages 32-44.
Crossref
Crossref
Robert Lee Hull & Joseph Pepping. (2016) Phenytoin Toxicity Due to Severe Liver Disease. Drug Intelligence & Clinical Pharmacy 11:1, pages 57-58.
Crossref
Crossref
A. Breckenridge, M.R. Bending & G. Brunner. 1977. Microsomes and Drug Oxidations. Microsomes and Drug Oxidations
385
394
.
G.R. Wilkinson & S. Schenker. (1976) Effects of liver disease on drug disposition in man. Biochemical Pharmacology 25:24, pages 2675-2681.
Crossref
Crossref
Ulrich Klotz. (1976) Influence of liver disease on the elimination of drugs. European Journal of Drug Metabolism and Pharmacokinetics 1:3, pages 129-140.
Crossref
Crossref